av/vivoryon-therapeutics-n-v--big.svg

COM:VIVORYON

Vivoryon Therapeutics AG

  • Stock

Last Close

2.31

04/11 13:21

Market Cap

49.61M

Beta: -

Volume Today

854

Avg: -

  • locale

    deGermany
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.vivoryon.com/
  • ipo date

    Apr 23, 2015

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has co...Show More

competitor of